BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
08. April 2024 07:45 ET
|
BioRestorative Therapies, Inc
— Collaboration follows recent manufacturing/clinical process enhancements that have tripled monthly trial capacity — — Patient enrollment expected to be completed in 2024 — ...
BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
13. Juni 2022 07:00 ET
|
BioRestorative Therapies, Inc
-- First Site Will Enroll First Patient in the Clinical Study-- MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:...
BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer
10. November 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced...
BioRestorative Therapies Prices $23 Million Public Offering and Uplisting to the Nasdaq Capital Market
04. November 2021 21:21 ET
|
BioRestorative Therapies, Inc
Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “BRTX” November 5, 2021 MELVILLE, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc....
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
02. September 2021 09:00 ET
|
BioRestorative Therapies, Inc
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program
31. August 2021 09:00 ET
|
BioRestorative Therapies, Inc
Patent Issued Grants Protection for Deriving Brown Adipocytes from Brown Adipose (Fat)-Derived Stem Cells MELVILLE, N.Y., Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the...
BioRestorative Therapies to Present at the Emerging Growth Conference on June 9, 2021
07. Juni 2021 06:00 ET
|
BioRestorative Therapies, Inc
BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference. ...
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
10. Mai 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
23. Oktober 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...